Participant-centric study design has advanced, but site-centric execution has not kept pace. In the Journal for Clinical Studies, Brian Mallon examines how unclear expectations, administrative burden and contract delays ...
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Confidently compliant? Considerations for industry players to meet the new EMA guideline
Vesta Marciulioniene, Director, Global Regulatory Clinical Services and Jo Hulbert, Executive Director, Global Regulatory Clinical Services provide an overview of the EMA’s new framework on computerised systems and electronic data in clinical trials in this article from XTalks Clinical Edge.
-
Dublin-headquartered Icon plc reports double-digit third quarter profit growth
This article from the Business Post reports that Icon plc has reported double-digit profit growth for the third quarter of 2023.
-
ICON releases Q3 financial results
CFO Brendan Brennan is interviewed by Emmet Oliver on Newstalk’s Breakfast Business on ICON’s Q3 2023 financial results.
-
Outsourcing Model Usage and its Relationship to Clinical Trial Performance
This article provides details on recent ICON plc collaboration with Tufts CSDD on a pilot study that seeks to validate new and more granular outsourcing model classifications in differentiating performance across custom contract-service approaches.
-
Centred on decentralised trials: Q&A with Harpreet Gill
In this article on Pharmaceutical Executive’s website, Harpreet Gill discusses how DCTs can transform clinical trials and improve the patient experience.
-
Automation in Clinical Trials
This article will explore how clinical trials have become more complex with more moving parts, along with the requirements for technology specific automation - increasing sophistication and the strategies for adoption.
Published by Journal for Clinical Studies Volume 15 Issue 3
-
Navigating the data-rich landscape of healthcare: The utility of data exploration and visualisation
In the ever-expanding universe of real world data, exploration and visualization strategies have become indispensable. This article presents 5 takeaways relevant to these strategies.
-
Narratives for a clinical study report: The evolution of automation and artificial intelligence
In this article (page 28), find out what the future holds for narrative production in clinical studies now that we are in the era of AI.
-
Keeping eCOAs off the critical path – key considerations
The prevalence of decentralised clinical trials and the importance of patient-centricity in medical practices are just two of many factors leading to the increased use of electronic Clinical Outcome Assessments (eCOAs). Digital devices like smartphones, tablets, wearables and web-based platforms are increasingly being used to measure the impact of a disease and/or treatment on patients’ quality of life and are an important way we can capture the patient’s voice in a clinical trial.
The eCOA system consists of the devices used for data collection, specialised eCOA software installed in these devices for collecting the data or access to web-based eCOA platforms and a centralised database or server to store, manage and analyse the data securely. This article explains how an optimised eCOA implementation strategy can minimise several risks and challenges associated with clinical trials.
Article published in International Pharmaceutical Industry, Volume 15 Issue 3, 29 September 2023
-
Modern partnerships with CROs
In this article in Contract Pharma, ICON SMEs share insight on strategic and blended outsourcing models and trends in today’s market.
